The specific insertion of FANCA in the AAVS1 site of FA‐A LCLs conferred an evident phenotypic correction of these cells, demonstrating therapeutic gene editing in FA‐A hematopoietic cells. The gene discussed is PPP1R12C; the disease is Friedreich ataxia.